Media
Femasys in the
Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
Featured
News
May 2026
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
Femasys received CE Mark approval for its FemHSG Catheter, expanding the company's fertility diagnostics portfolio into the European market.
Apr 1, 2026
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
Globe Newswire
Read ↗
Mar 31, 2026
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
GLOBE NEWSWIRE
Read ↗
Mar 18, 2026
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
GlobeNewswire
Read ↗
Mar 10, 2026
Femasys Shareholder Update – 2025 in Review
Femasys
Read ↗
Mar 10, 2026
Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment
Femasys IR
Read ↗
Feb 27, 2026
Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
Read ↗
Stay Current
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.